REGENERON PHARMACEUTICALS, INC. - FORM 10-K - EX-23.1 - CONSENT OF PRICEWATERHOUSECOOPERS LLP - February 12, 2015

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - REGENERON PHARMACEUTICALS, INC.Financial_Report.xls
EX-10.25.3 - 3RD AMENDMENT BETWEEN CREDIT SUISSE AND THE REGISTRANT - REGENERON PHARMACEUTICALS, INC.regn-ex_10253x12312014x10k.htm
EX-21.1 - SUBSIDIARIES OF REGENERON PHARMACEUTICALS, INC. - REGENERON PHARMACEUTICALS, INC.regn-ex_211x12312014x10k.htm
EX-10.25.2 - 2ND AMENDMENT BETWEEN CREDIT SUISSE AND THE REGISTRANT - REGENERON PHARMACEUTICALS, INC.regn-ex_10252x12312014x10k.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) - REGENERON PHARMACEUTICALS, INC.regn-ex_311x12312014x10k.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) - REGENERON PHARMACEUTICALS, INC.regn-ex_312x12312014x10k.htm
EX-32 - CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 - REGENERON PHARMACEUTICALS, INC.regn-ex_32x12312014x10k.htm
EX-10.21.2 - 2ND AMENDMENT BETWEEN GOLDMAN SACHS AND THE REGISTRANT - REGENERON PHARMACEUTICALS, INC.regn-ex_10212x12312014x10k.htm
10-K - 10-K - REGENERON PHARMACEUTICALS, INC.regn-123114x10k.htm
EX-10.10.1 - RESTATED AMENDMENT AGREEMENT BY AND BETWEEN BAYER HEALTHCARE AND THE REGISTRANT - REGENERON PHARMACEUTICALS, INC.regn-ex_10101x12312014x10k.htm


Exhibit 23.1


CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S‑8 (Nos. 333-61132, 333-97375, 333-119257, 333-151941, 333-169569, 333-174863, 333-196799, and 333-198794) and on Form S‑3 (No. 333-192091) of Regeneron Pharmaceuticals, Inc., of our report dated February 12, 2015 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.


/s/ PricewaterhouseCoopers LLP

Florham Park, New Jersey
February 12, 2015




REGENERON PHARMACEUTICALS, INC. Reports